Group One Trading’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Group One Trading's HAE Position: Q2 2026 in Review
Group One Trading reduced its Haemonetics (HAE) stake by 86% in Q2 2026, selling an estimated $26.2K and leaving 69 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #6718.
Group One Trading first reported a position in HAE in Q1 2014 and has held it in 14 quarters since. The position peaked at $230K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Group One Trading held 69 shares of Haemonetics worth $5.17K as of Q2 2026.
- Group One Trading sold 408 Haemonetics shares in Q2 2026, an estimated $26.2K.
- Haemonetics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6718 holding.
- Group One Trading first reported a position in Haemonetics in Q1 2014 and has held it in 14 quarters since.
- Group One Trading's Haemonetics position peaked at $230K in Q4 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.